Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Experimental Cell Research
|
July 22, 2004
Myosin light chain kinase (210 kDa) is a potential cytoskeleton integrator through its unique N-terminal domain
Dmitry S Kudryashov, Olga V Stepanova, Elena L Vilitkevich, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 26, 2014
An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis
Shannon L Macauley, Andrew M S Wong, Charles Shyng, et al.
Plos One
|
February 13, 2016
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses
Adam D Bachstetter, Zhengqiu Zhou, Rachel K Rowe, et al.
Plos One
|
December 15, 2010
Homodimerization of the death-associated protein kinase catalytic domain: development of a new small molecule fluorescent reporter
Michael Zimmermann, Cédric Atmanene, Qingyan Xu, et al.
Clinical Pharmacology in Drug Development
|
April 8, 2020
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers
Linda J Van Eldik, Lumy Sawaki, Karen Bowen, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 9, 2010
Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury
Tamara Mirzapoiazova, Jaideep Moitra, Liliana Moreno-Vinasco, et al.
ACS Chemical Neuroscience
|
February 14, 2015
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models
Saktimayee M Roy, Valerie L Grum-Tokars, James P Schavocky, et al.
The Journal of Clinical Investigation
|
November 18, 2025
USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I
Kun Liu, Radhika Iyer, Yi Li, et al.
Plos One
|
July 11, 2013
Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
D Martin Watterson, Valerie L Grum-Tokars, Saktimayee M Roy, et al.
Plos One
|
June 19, 2013
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase
Gerardo A Morfini, Daryl A Bosco, Hannah Brown, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Experimental Cell Research
|
July 22, 2004
Myosin light chain kinase (210 kDa) is a potential cytoskeleton integrator through its unique N-terminal domain
Dmitry S Kudryashov, Olga V Stepanova, Elena L Vilitkevich, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 26, 2014
An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis
Shannon L Macauley, Andrew M S Wong, Charles Shyng, et al.
Plos One
|
February 13, 2016
MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses
Adam D Bachstetter, Zhengqiu Zhou, Rachel K Rowe, et al.
Plos One
|
December 15, 2010
Homodimerization of the death-associated protein kinase catalytic domain: development of a new small molecule fluorescent reporter
Michael Zimmermann, Cédric Atmanene, Qingyan Xu, et al.
Clinical Pharmacology in Drug Development
|
April 8, 2020
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers
Linda J Van Eldik, Lumy Sawaki, Karen Bowen, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 9, 2010
Non-muscle myosin light chain kinase isoform is a viable molecular target in acute inflammatory lung injury
Tamara Mirzapoiazova, Jaideep Moitra, Liliana Moreno-Vinasco, et al.
ACS Chemical Neuroscience
|
February 14, 2015
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models
Saktimayee M Roy, Valerie L Grum-Tokars, James P Schavocky, et al.
The Journal of Clinical Investigation
|
November 18, 2025
USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I
Kun Liu, Radhika Iyer, Yi Li, et al.
Plos One
|
July 11, 2013
Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
D Martin Watterson, Valerie L Grum-Tokars, Saktimayee M Roy, et al.
Plos One
|
June 19, 2013
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase
Gerardo A Morfini, Daryl A Bosco, Hannah Brown, et al.
Page
of 8